Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis

Drug and Alcohol Dependence

Volumn 154, Issue , 2015, Pages 1-13

  Lai, Harry Man Xiong ^a   Cleary, Michelle ^b   Sitharthan, Thiagarajan ^a   Hunt, Glenn E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Anxiety; Comorbidity; Depression; Meta analysis; Prevalence; Substance use disorders

Indexed keywords

ILLICIT DRUG;

AGORAPHOBIA; ALCOHOL USE DISORDER; ALCOHOLISM; ANXIETY DISORDER; BIPOLAR DISORDER; COMORBIDITY; DATA ABSTRACTION; DATA PROCESSING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DEPENDENCE; DYSTHYMIA; EPIDEMIOLOGICAL DATA; GENERALIZED ANXIETY DISORDER; HUMAN; INTERRATER RELIABILITY; MAJOR DEPRESSION; MOOD DISORDER; PANIC; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK; RISK OF BIAS; SOCIAL PHOBIA; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; ADULT; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; META ANALYSIS; ODDS RATIO; SUBSTANCE-RELATED DISORDERS;

SCOPUS;

ADULT; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; ODDS RATIO; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 84938973475     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.05.031     Document Type: Review

References (101)

1. Alegria M., Takeuchi D., Canino G., Duan N., Shrout P., Meng X.L., Vega W., Zane N., Vila D., Woo M., Vera M., Guarnaccia P., Aguilar-Gaziola S., Sue S., Escobar J., Lin K.M., Gong F. Considering context, place and culture: the National Latino and Asian American Study. Int. J. Methods Psychiatr. Res. 2004, 13:208-220.
2. Almeida-Filho N., Lessa I., Magalhaes L., Arauho M.J., Aquino E., de Jesus M.J. Co-occurrence patterns of anxiety, depression and alcohol use disorders. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:423-431.
3. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., De Girolamo G., De Graaf R., Demyttenaere K., Gasquet I., Haro J.M., Katz S.J., Kessler R.C., Kovess V., Lepine J.P., Ormel J., Polidori G., Russo L.J., Vilagut G., Almansa J., Arbabzadeh-Bouchez S., Autonell J., Bernal M., Buist-Bouwman M.A., Codony M., Domingo-Salvany A., Ferrer M., Joo S.S., Martinez-Alonso M., Matschinger H., Mazzi F., Morgan Z., Morosini P., Palacin C., Romera B., Taub N., Vollebergh W.A.M. 12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr. Scand. 2004, 109(Suppl. 420):28-37.
4. Alonso J., Lepine J.P., Scientific Committee Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J. Clin. Psychiatry 2007, 68(Suppl. 2):3-9.
5. Alonso J., Vilagut G., Chatterji S., Heeringa S., Schoenbaum M., Bedirhan U.T., Rojas-Farreras S., Angermeyer M., Bromet E., Bruffaerts R., De Girolamo G., Gureje O., Haro J.M., Karam A.N., Kovess V., Levinson D., Liu Z., Medina-Mora M.E., Ormel J., Posada-Villa J., Uda H., Kessler R.C. Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys. Psychol. Med. 2011, 41:873-886.
6. Angst J., Dobler-Mikola A., Binder J. The Zurich study - a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology. Eur. Arch. Psychiatry Neurol. Sci. 1984, 234:13-20.
7. Bijl R.V., Ravelli A., Van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc. Psychiatry Psychiatr. Epidemiol. 1998, 33:587-595.
8. Bott K., Meyer C., Rumpf H.J., Hapke U., John U. Psychiatric disorders among at-risk consumers of alcohol in the general population. J. Stud. Alcohol 2005, 66:246-253.
9. Bromet E.J., Gluzman S.F., Paniotto V.I., Webb C.P., Tintle N.L., Zakhozha V., Havenaar J.M., Gutkovich Z., Kostyuchenko S., Schwartz J.E. Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc. Psychiatry Psychiatr. Epidemiol. 2005, 40:681-690.
10. Bulloch A., Lavorato D., Williams J., Patten S. Alcohol consumption and major depression in the general population: the critical importance of dependence. Depress. Anxiety 2012, 29:1058-1064.
11. Burns L., Teesson M. Alcohol use disorders comorbid with anxiety, depression and drug use disorders: findings from the Australian National Survey of Mental Health and well being. Drug Alcohol Depend. 2002, 68:299-307.
12. Canino G.J., Bird H.R., Shrout P.E., Rubio-Stipec M., Bravo M., Martinez R., Sesman M., Guevara L.M. The prevalence of specific psychiatric disorders in Puerto Rico. Arch. Gen. Psychiatry 1987, 44:727-735.
13. Caraveo-Anduaga J.J., Bermudez E.C. Psychiatric disorders and substance abuse in Mexico: epidemiological perspective. Salud Mental 2002, 25:9-15. [Spanish].
14. Cerda M., Sagdeo A., Galea S. Comorbid forms of psychopathology: key patterns and future research directions. Epidemiol. Rev. 2008, 30:155-177.
15. Cho M.J., Kim J.K., Jeon H.J., Suh T., Chung I.W., Hong J.P., Bae J.N., Lee D.W., Park J.I., Cho S.J., Lee C.K., Hahm B.J. Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults. J. Nerv. Ment. Dis. 2007, 195:203-210.
16. Chou S.P., Lee H.K., Cho M.J., Park J.I., Dawson D.A., Grant B.F. Alcohol use disorders, nicotine dependence, and co-occurring mood and anxiety disorders in the United States and South Korea - a cross-national comparison. Alcohol Clin. Exp. Res. 2012, 36:654-662.
17. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2007, 64:566-576.
18. Conway K.P., Compton W., Stinson F.S., Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J. Clin. Psychiatry 2006, 67:247-257.
19. Crawford V., Crome I.B., Clancy C. Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drug-Educ. Prev. Polic. 2003, 10:S1-S74.
20. Cuffel B.J. Comorbid substance use disorder: prevalence, patterns of use, and course. New Dir. Ment. Health Serv. 1996, 70:93-105.
21. Currie S.R., Patten S.B., Williams J.V.A., Wang J., Beck C.A., El-Guebaly N., Maxwell C. Comorbidity of major depression with substance use disorders. Can. J. Psychiatry 2005, 50:660-666.
22. De Graaf R., Bijl R.V., Smit F., Vollebergh W.A.M., Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am. J. Psychiatry 2002, 159:620-629.
23. Degenhardt L., Chiu W.T., Sampson N., Kessler R.C., Anthony J.C., Angermeyer M., Bruffaerts R., De Girolamo G., Gureje O., Huang Y., Karam A., Kostyuchenko S., Lepine J.P., Mora M.E., Neumark Y., Ormel J.H., Pinto-Meza A., Posada-Villa J., Stein D.J., Takeshima T., Wells J.E. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008, 5:e141.
24. Dickersin K. Systematic reviews in epidemiology: why are we so far behind?. Int. J. Epidemiol. 2002, 31:6-12.
25. Drake R.E., O'Neal E.L., Wallach M.A. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J. Subst. Abuse Treat. 2008, 34:123-138.
26. Eaton N.R., Krueger R.F., Markon K.E., Keyes K.M., Skodol A.E., Wall M., Hasin D.S., Grant B.F. The structure and predictive validity of the internalizing disorders. J. Abnorm. Psychol. 2013, 122:86-92.
27. Farrell M., Howes S., Bebbington P., Brugha T., Jenkins R., Lewis G., Marsden J., Taylor C., Meltzer H. Nicotine, alcohol and drug dependence and psychiatric comorbidity: results of a national household survey. Br. J. Psychiatry 2001, 179:432-437.
28. Graham H.L., Maslin J., Copello A., Birchwood M., Mueser K., McGovern D., Georgiou G. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc. Psychiatry Psychiatr. Epidemiol. 2001, 36:448-455.
29. Grant B.F. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J. Subs. Abuse 1995, 7:481-497.
30. Grant B.F., Goldstein R.B., Chou S.P., Huang B., Stinson F.S., Dawson D.A., Saha T.D., Smith S.M., Pulay A.J., Pickering R.P., Ruan W.J., Compton W.M. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on alcohol and related conditions. Mol. Psychiatr. 2009, 14:1051-1066.
31. Grant B.F., Harford T.C. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995, 39:197-206.
32. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Ruan W.J., Goldstein R.B., Smith S.M., Saha T.D., Huang B. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on alcohol and related conditions. Psychol. Med. 2005, 35:1747-1759.
33. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
34. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Ruan W.J., Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J. Clin. Psychiatry 2005, 66:1205-1215.
35. Gratzer D., Levitan R.D., Sheldon T., Toneatto T., Rector N.A., Goering P. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario. J. Affective Disord. 2004, 79:209-215.
36. Hall W., Degenhardt L., Teesson M. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base. Addict. Behav. 2009, 34:526-530.
37. Hanna E.Z., Grant B.F. Gender differences in DSM-IV alcohol use disorders and major depression as distributed in the general population: clinical implications. Compr. Psychiatry 1997, 38:202-212.
38. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on alcoholism and related conditions. Arch. Gen. Psychiatry 2005, 62:1097-1106.
39. Horsfall J., Cleary M., Hunt G.E., Walter G. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harv. Rev. Psychiatry 2009, 17:24-34.
40. Hoy D., Brooks P., Woolf A., Blyth F., March L., Bain C., Baker P., Smith E., Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J. Clin. Epidemiol. 2012, 65:934-939.
41. Hunt G.E., Siegfried N., Morley K., Sitharthan T., Cleary M. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst. Rev. 2013, (10). Art. No: CD001088.
42. Jackson J.S., Torres M., Caldwell C.H., Neighbors H.W., Nesse R.M., Taylor R.J., Trierweiler S.J., Williams D.R. The National Survey of American Life: a study of racial, ethnic and cultural influences on mental disorders and mental health. Int. J. Methods Psychiatr. Res. 2004, 13:196-207.
43. Jane-Llopis E., Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006, 25:515-536.
44. Jenkins R., Lewis G., Bebbington P., Brugha T., Farrell M., Gill B., Meltzer H. The National Psychiatric Morbidity surveys of Great Britain - initial findings from the household survey. Psychol. Med. 1997, 27:775-789.
45. Jeon H.J., Suh T., Lee H.J., Hahm B.J., Lee J.Y., Cho S.J., Lee Y.R., Chang S.M., Cho M.J. Partial versus full PTSD in the Korean community: prevalence, duration, correlates, comorbidity, and dysfunctions. Depress. Anxiety 2007, 24:577-585.
46. Kandel D.B., Huang F.Y., Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001, 64:233-241.
47. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for alcohol use disorders in men. Twin Res. Hum. Genet. 2011, 14:1-15.
48. Kessler R.C. The epidemiology of dual diagnosis. Biol. Psychiatry 2004, 56:730-737.
49. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 2003, 289:3095-3105.
50. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
51. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am. J. Orthopsychiatry 1996, 66:17-31.
52. Kessler R.C., Ormel J., Petukhova M., McLaughlin K.A., Green J.G., Russo L.J., Stein D.J., Zaslavsky A.M., Aguilar-Gaziola S., Alonso J., Andrade L., Benjet C., De Girolamo G., De Graaf R., Demyttenaere K., Fayyad J., Haro J.M., Hu C., Karam A., Lee S., Lepine J.P., Matchsinger H., Mihaescu-Pintia C., Posada-Villa J., Sagar R., Ustun T.B. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch. Gen. Psychiatry 2011, 68:90-100.
53. Kessler R.C., Tat Chiu W., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
54. Kushner M.G., Abrams K., Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin. Psychol. Rev. 2000, 20:149-171.
55. Kushner M.G., Wall M.M., Krueger R.F., Sher K.J., Maurer E., Thuras P., Lee S. Alcohol dependence is related to overall internalizing psychopathology load rather than to particular internalizing disorders: evidence from a national sample. Alcohol Clin. Exp. Res. 2012, 36:325-331.
56. Lai H.M., Sitharthan T. A six-year study of substance use and mental health disorders: ascertaining the prevalence of comorbidity. Drugs Alcohol Today 2012, 12:180-186.
57. Leray E., Camara A., Drapier D., Riou F., Bougeant N., Pelissolo A., Lloyd K.R., Bellamy V., Roelandt J.L., Millet B. Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" survey (MHGP). Eur. Psychiatry 2011, 26:339-345.
58. Liang W., Lenton S., Allsop S., Chikritzhs T. Does availability of illicit drugs mediate the association between mental illness and substance use?. Subst. Use Misuse 2011, 46:1304-1308.
59. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann. Intern. Med. 2009, 151:W65-W94.
60. Marquenie L.A., Schade A., Van Balkom A.J., Comijs H.C., De Graaf R., Vollebergh W., Van Dyck R., Van Den Brink W. Origin of the comorbidity of anxiety disorders and alcohol dependence: findings of a general population study. Eur. Addict. Res. 2007, 13:39-49.
61. McEvoy P.M., Grove R., Slade T. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing. Aust. N. Z. J. Psychiatry 2011, 45:957-967.
62. McGovern M.P., Xie H., Segal S.R., Siembab L., Drake R.E. Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. J. Subst. Abuse Treat. 2006, 31:267-275.
63. Medina-Mora M.E., Borges G., Benjet C., Lara C., Berglund P. Psychiatric disorders in Mexico: lifetime prevalence in a nationally representative sample. Br. J. Psychiatry 2007, 190:521-528.
64. Menezes P.R., Johnson S., Thornicroft G., Marshall J., Prosser D., Bebbington P., Kuipers E. Drug and alcohol problems among individuals with severe mental illness in south London. Br. J. Psychiatry 1996, 168:612-619.
65. Mericle A.A., Ta Park V.M., Holck P., Arria A.M. Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity. Compr. Psychiatry 2012, 53:657-665.
66. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M.A., Petukhova M., Kessler R.C. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch. Gen. Psychiatry 2007, 64:543-552.
67. Merikangas K.R., Angst J., Eaton W., Canino G., Rubio-Stipec M., Wacker H., Wittchen H.U., Andrade L., Essau C., Whitaker A., Kraemer H., Robins L.N., Kupfer D.J. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br. J. Psychiatry 1996, 168(Suppl. 30):58-67.
68. Merikangas K.R., Gelernter C.S. Comorbidity for alcoholism and depression. Psychiatr. Clin. N. Am. 1990, 13:613-632.
69. Merikangas K.R., Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr. Opin. Psychiatry 2007, 20:353-358.
70. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Aguilar-Gaziola S., Bijl R., Borges G., Caraveo-Anduaga J.J., DeWit D.J., Kolody B., Vega W.A., Wittchen H.U., Kessler R.C. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict. Behav. 1998, 23:893-907.
71. Meyer C., Rumpf H.J., Hapke U., Dilling H., John U. Prevalence of alcohol consumption, abuse and dependence in a country with high per capita consumption: findings from the German TACOS study. Transitions in alcohol consumption and smoking. Soc. Psychiatry Psychiatr. Epidemiol. 2000, 35:539-547.
72. Mills K., Deady M., Proudfoot H., Sannibale C., Teesson M., Mattick R., Burns L. Guidelines on the Management of Co-occurring Alcohol and Other Drug and Mental Health Conditions in Alcohol and Other Drug Treatment Settings 2009, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
73. Mills K.L., Deady M., Teesson M., Sannibale C., Proudfoot H., Burns L., Mattick R. Guidelines on the management of co-occurring mental health conditions in alcohol and other drug treatment settings: how useful are they?. Ment. Health Subst. Use 2012, 5:160-172.
74. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009, 3:e123-e130.
75. Offord D.R., Boyle M.H., Campbell D., Goering P., Lin E., Wong M., Racine Y.A. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can. J. Psychiatry 1996, 41:559-563.
76. Pettinati H.M., O'Brien C.P., Dundon W.D. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am. J. Psychiatry 2013, 170:23-30.
77. Pirkola S.P., Isometsä E., Suvisaari J., Aro H., Joukamaa M., Poikolainen K., Koskinen S., Aromaa A., Lönnqvist J.K. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population. Results from the Health 2000 Study. Soc. Psychiatry Psychiatr. Epidemiol. 2005, 40:1-10.
78. Ravelli A., Bijl R.V., Van Zessen G. Comorbidity of psychiatric disorders in the Dutch population; results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) (Dutch). Tijdschrift voor Psychaitrie 1998, 40:531-544.
79. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiological catchment area (ECA) study. J. Am. Med. Assoc. 1990, 264:2511-2518.
80. Rosenthal R.N., Nunes E.V., Le Fauve C.E. Implications of epidemiological data for identifying persons with substance use and other mental disorders. Am. J. Addict. 2012, 21:97-103.
81. Ross H.E., Glaser F.B., Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch. Gen. Psychiatry 1988, 45:1023-1031.
82. Rush B., Urbanoski K., Bassani D., Castel S., Wild T.C., Strike C., Kimberley D., Somers J. Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Can. J. Psychiatry 2008, 53:800-809.
83. Samet S., Nunes E.V., Hasin D. Diagnosing comorbidity: concepts, criteria, and methods. Acta Neuropsychiatr. 2004, 16:9-18.
84. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting: meta-analysis of observational studies in epidemiology (MOOSE) group. J. Am. Med. Assoc. 2000, 283:2008-2012.
85. Subramaniam M., Abdin E., Vaingankar J., Phua A.M., Tee J., Chong S.A. Prevalence and correlates of alcohol use disorders in the Singapore Mental Health Survey. Addiction 2012, 107:1443-1452.
86. Subramaniam M., Abdin E., Vaingankar J.A., Chong S.A. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. J. Affect. Disord. 2013, 146:189-196.
87. Suttajit S., Kittirattanapaiboon P., Junsirimongkol B., Likhitsathian S., Srisurapanont M. Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: findings from the 2008 Thai National Mental Health survey. Addict. Behav. 2012, 37:1395-1399.
88. Swartz J.A., Lurigio A.J. Screening for serious mental illness in populations with co-occurring substance use disorders: performance of the K6 scale. J. Subst. Abuse Treat. 2006, 31:287-296.
89. Swendsen J.D., Merikangas K.R. The comorbidity of depression and substance use disorders. Clin. Psychol. Rev. 2000, 20:173-189.
90. Swendsen J.D., Merikangas K.R., Canino G.J., Kessler R.C., Rubio-Stipec M., Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr. Psychiatry 1998, 39:176-184.
91. Teesson M., Hall W., Lynskey M., Degenhardt L. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust. N. Z. J. Psychiatry 2000, 34:206-213.
92. Teesson M., Hall W., Slade T., Mills K., Grove R., Mewton L., Baillie A., Haber P. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction 2010, 105:2085-2094.
93. Tickell C. Comorbidity - the social implications. Drug-Educ. Prev. Polic. 1999, 6:175-179.
94. Tiet Q.Q., Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol Clin. Exp. Res. 2007, 31:513-536.
95. Torrens M., Rossi P.C., Martinez-Riera R., Martinez-Sanvisens D., Bulbena A. Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system?. Subst. Use Misuse 2012, 47:1005-1014.
96. Vega W.A., Canino G., Cao Z., Alegria M. Prevalence and correlates of dual diagnoses in US. Latinos. Drug Alcohol Depend. 2009, 100:32-38.
97. Vega W.A., Kolody B., guilar-Gaxiola S., Alderete E., Catalano R., Caraveo-Anduaga J. Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California. Arch. Gen. Psychiatry 1998, 55:771-778.
98. Vega W.A., Sribney W.M., Achara-Abrahams I. Co-occurring alcohol, drug, and other psychiatric disorders among Mexican-origin people in the United States. Am. J. Public Health 2003, 93:1057-1064.
99. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., Burstein R., Murray C.J., Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013, 382:1575-1586.
100. Wittchen H.U., Essau C.A., von Zerssen D., Krieg J.C., Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur. Arch. Psychiatry Clin. Neurosci. 1992, 241:247-258.
101. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jonsson B., Olesen J., Allgulander C., Alonso J., Faravelli C., Fratiglioni L., Jennum P., Lieb R., Maercker A., van Os J., Preisig M., Salvador-Carulla L., Simon R., Steinhausen H.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharm. 2011, 21:655-679.